Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 10606852)

Published in Br J Dermatol on December 01, 1999

Authors

M Bhushan1, B McLaughlin, J B Weiss, C E Griffiths

Author Affiliations

1: Dermatology Centre, University of Manchester, Hope Hospital, UK.

Articles citing this

Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet (2011) 1.74

Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med (2010) 1.69

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A (2010) 1.56

Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol (2009) 1.49

Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer. Indian J Dermatol (2014) 1.43

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res Ther (2004) 1.09

Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol (2005) 1.09

The cutaneous vascular system in chronic skin inflammation. J Investig Dermatol Symp Proc (2011) 1.06

Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. Am J Pathol (2008) 1.05

A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. Am J Pathol (2005) 1.04

Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways. J Biol Chem (2009) 1.01

Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis. Blood (2004) 1.01

An important role of blood and lymphatic vessels in inflammation and allergy. J Allergy (Cairo) (2013) 0.94

Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. J Cell Mol Med (2008) 0.92

Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol (2014) 0.88

Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha. J Autoimmune Dis (2006) 0.86

Differential expression of the angiogenesis growth factors in psoriasis vulgaris. BMC Res Notes (2012) 0.84

An important role of the SDF-1/CXCR4 axis in chronic skin inflammation. PLoS One (2014) 0.83

Psoriasis: advances in pathophysiology and management. Postgrad Med J (2007) 0.82

IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell Cycle (2014) 0.82

Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin Cosmet Investig Dermatol (2013) 0.81

Chemokine-like factor 1-derived C-terminal peptides induce the proliferation of dermal microvascular endothelial cells in psoriasis. PLoS One (2015) 0.80

Extracellular matrix modulates angiogenesis in physiological and pathological conditions. Biomed Res Int (2014) 0.80

Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases. Indian J Dermatol (2010) 0.79

A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues. BMC Biotechnol (2011) 0.77

Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene. Ann Dermatol (2016) 0.77

Tyrosine kinases in inflammatory dermatologic disease. J Am Acad Dermatol (2010) 0.76

Tazarotene-induced gene 3 may affect inflammatory angiogenesis in psoriasis by downregulating placental growth factor expression. Ann Dermatol (2014) 0.76

VEGF involvement in psoriasis. Clujul Med (2015) 0.76

Expression of Angiogenic Factors in Psoriasis Vulgaris. J Clin Diagn Res (2017) 0.75

Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment. An Bras Dermatol (2014) 0.75

Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition. Biomol Ther (Seoul) (2015) 0.75

Articles by these authors

(truncated to the top 100)

Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med (1982) 5.03

Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA (1998) 4.36

The antifolding activity of SecB promotes the export of the E. coli maltose-binding protein. Cell (1988) 3.74

Keratinocytes as initiators of inflammation. Lancet (1991) 3.68

Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol (1996) 3.19

Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med (1996) 2.92

Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis (2000) 2.71

Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci U S A (1998) 2.66

Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis (2000) 2.63

Multiplex PCR assay and simple preparation method for stool specimens detect enterotoxigenic Escherichia coli DNA during course of infection. J Clin Microbiol (1995) 2.33

Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem (2000) 2.29

Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol (1991) 2.24

Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med (1993) 2.15

Therapy for psoriatic arthritis: sometimes a conflict for psoriasis. Br J Rheumatol (1997) 2.03

Neurobehavioral responses of newborn infants after maternal epidural anesthesia. Anesthesiology (1974) 2.00

Isolation and characterisation of an unusual collagen from hyaline cartilage and intervertebral disc. FEBS Lett (1981) 1.89

Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol (1993) 1.86

Neurobehavioral responses and drug concentrations in newborns after maternal epidural anesthesia with bupivacaine. Anesthesiology (1976) 1.86

What patients with psoriasis believe about their condition. J Am Acad Dermatol (1998) 1.85

The outcomes of elective laparoscopic and open cholecystectomies. J Am Coll Surg (1995) 1.79

Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol (2000) 1.76

Clearance of psoriasis with low dose cyclosporin. Br Med J (Clin Res Ed) (1986) 1.75

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73

The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol (2000) 1.69

Influence of local anesthetic solution on postdural puncture headache. Anesthesiology (1990) 1.69

Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med (1990) 1.68

Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar. J Infect Dis (1999) 1.64

Comparison of teleconsultations and face-to-face consultations: preliminary results of a United Kingdom multicentre teledermatology study. Br J Dermatol (1998) 1.63

Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol (1989) 1.60

Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol (1995) 1.60

Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis (1998) 1.55

The benefits of HIV antibody testing of saliva in field research. Can J Public Health (1992) 1.54

Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol (1990) 1.53

The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis. Br J Dermatol (1987) 1.53

Specific detection of toxigenic strains of Clostridium difficile in stool specimens. J Clin Microbiol (1993) 1.52

Rapid diagnosis by electron microscopy of nonbacterial gastroenteritis in children. Can Med Assoc J (1980) 1.50

Angiogenic factor from synovial fluid resembling that from tumours. Lancet (1980) 1.46

Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability. Arch Dermatol (2000) 1.41

Investigation of cytomegalovirus and human herpes viruses 6 and 7 as possible causative antigens in psoriasis. Acta Derm Venereol (2001) 1.41

A pilot study of the effect of oral 8-methoxypsoralen and intraarticular ultraviolet light on rheumatoid synovitis. J Rheumatol (1995) 1.40

Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis (1997) 1.40

Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol (1994) 1.39

Discordance between facial wrinkling and the presence of basal cell carcinoma. Arch Dermatol (2001) 1.39

Adverse effect of lignocaine (Lidocaine) on skin destined for tissue culture. J Invest Dermatol (1990) 1.39

Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol (1999) 1.38

Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol (1994) 1.36

Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol (1990) 1.33

Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas. Science (1989) 1.32

Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol (1995) 1.31

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol (1997) 1.30

Gluten-sensitive enteropathy. Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to wheat gliadin. J Clin Invest (1983) 1.30

The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update. J Invest Dermatol (1990) 1.29

Epidemic Serratia marcescens in a neonatal intensive care unit: importance of the gastrointestinal tract as a reservoir. Infect Control (1982) 1.29

Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin Exp Immunol (1985) 1.29

The role of clinical opinion leaders in guideline implementation and quality improvement. Chest (2000) 1.28

All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Invest (1994) 1.28

Patients with psoriasis and their compliance with medication. J Am Acad Dermatol (1999) 1.28

Characterisation of another short-chain disulphide-bonded collagen from cartilage, vitreous and intervertebral disc. FEBS Lett (1982) 1.27

An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis (1998) 1.26

Solid-phase radioimmunoassay for the detection of antibodies to collagen. J Immunol Methods (1979) 1.26

Effect of oxygen tension on the quantities of procollagenase-activating angiogenic factor present in the developing kitten retina. Br J Ophthalmol (1986) 1.24

Localisation of collagen types and fibronectin in cartilage by immunofluorescence. Ann Rheum Dis (1983) 1.23

The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. Am J Pathol (1989) 1.21

An angiogenic factor isolated from tumours: a potent low-molecular-weight compound. Br J Cancer (1979) 1.21

Treatment of nongonococcal urethritis with ciprofloxacin. Am J Med (1987) 1.18

Consultation between cardiologists and generalists in the management of acute myocardial infarction: implications for quality of care. Arch Intern Med (1998) 1.17

Electron microscope studies of the effects of endo- and exopeptidase digestion on tropocollagen. A novel concept of the role of terminal regions in fibrillogenesis. Biochim Biophys Acta (1970) 1.15

Rapid detection of human viruses in faeces by a simple and routine immune electron microscopy technique. J Gen Virol (1981) 1.14

Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J Infect Dis (1998) 1.13

Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol (2000) 1.13

Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. J Invest Dermatol (1991) 1.13

Effects of all-trans retinoic acid and Ca++ on human skin in organ culture. Am J Pathol (1993) 1.12

Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ (2000) 1.11

The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol (2000) 1.10

Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther (1998) 1.10

Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle. J Appl Physiol (1985) (1998) 1.10

Specific detection of Clostridium difficile toxin A gene sequences in clinical isolates. Mol Cell Probes (1994) 1.10

Langerhans cell migration. Clin Exp Dermatol (2000) 1.09

Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. J Clin Invest (1992) 1.09

Immunoglobulin allotype markers in gluten-sensitive enteropathy. Lancet (1983) 1.09

Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol (1992) 1.09

Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. Clin Exp Dermatol (2001) 1.08

A new method of fetal heart rate monitoring. Obstet Gynecol (1975) 1.08

Laboratory diagnosis of the first cases of HIV-2 infection in Canada. CMAJ (1989) 1.08

Genital ulcers: etiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica. Clin Infect Dis (1999) 1.08

Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol (2001) 1.07

The hemolytic uremic syndrome associated with ECHO 22 infection. Clin Pediatr (Phila) (1980) 1.07

The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res (2001) 1.06

Lassa fever: the first confirmed case imported into Canada. Can Dis Wkly Rep (1989) 1.05

The origin of HIV-1 isolate HTLV-IIIB. Nature (1993) 1.05

A low-molecular-weight angiogenic factor in cat retina. Br J Ophthalmol (1982) 1.05

Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle-associated antigen (Ki-67) in mycosis fungoides. Am J Pathol (1990) 1.04

Direct vision gastric biopsy using the Machida FGS-B6 gastroscope. Gastrointest Endosc (1970) 1.04

1 Alpha 2 alpha 3 alpha collagen is arthritogenic. Ann Rheum Dis (1983) 1.04

Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat (2001) 1.03

The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing. Clin Invest Med (1992) 1.03

Stimulation by a low-molecular-weight angiogenic factor of capillary endothelial cells in culture. Br J Cancer (1980) 1.03

Fibrillin microfibrils are reduced in skin exhibiting striae distensae. Br J Dermatol (1998) 1.03

Enzymic degradation of collagen. Int Rev Connect Tissue Res (1976) 1.02

Urinary peptides derived from the cross-linked regions of connective tissue proteins. Nature (1968) 1.02